Back
NeuroBo Pharmaceuticals Stock Price Chart
Sponsored
NRBO
Sponsored
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
19
NRBO
NeuroBo Pharmaceuticals
Last Price:
2.73
Seasonality Move:
-18.3%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRBO is experiencing selling pressure, which indicates risk of future bearish movement.
NeuroBo Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.68 | Sell |
20-day SMA: | 2.71 | Sell |
50-day SMA: | 3.09 | Sell |
200-day SMA: | 3.94 | Sell |
8-day EMA: | 2.65 | Sell |
20-day EMA: | 2.76 | Sell |
50-day EMA: | 3.06 | Sell |
200-day EMA: | 5 | Sell |
NeuroBo Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 38 | Sell |
Chaikin Money Flow: | -18122 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.56 - 2.88) | Sell |
Bollinger Bands (100): | (2.95 - 4.31) | Sell |
NeuroBo Pharmaceuticals Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for NeuroBo Pharmaceuticals Stock
Is NeuroBo Pharmaceuticals Stock a Buy?
- NeuroBo Pharmaceuticals share price is 2.54 while NRBO 8-day simple moving average is 2.68, which is a Sell signal.
- The stock price of NRBO is 2.54 while NeuroBo Pharmaceuticals 20-day SMA is 2.71, which makes it a Sell.
- NeuroBo Pharmaceuticals 50-day simple moving average is 3.09 while NRBO share price is 2.54, making it a Sell technically.
- NRBO stock price is 2.54 and NeuroBo Pharmaceuticals 200-day simple moving average is 3.94, creating a Sell signal.
NRBO Technical Analysis vs Fundamental Analysis
Sell
19
NeuroBo Pharmaceuticals (NRBO)
is a Sell
Is NeuroBo Pharmaceuticals a Buy or a Sell?
-
NeuroBo Pharmaceuticals stock is rated a Sell
The current NeuroBo Pharmaceuticals [NRBO] share price is $2.54. The Score for NRBO is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
NeuroBo Pharmaceuticals Stock Info
Market Cap:
21.56M
Price in USD:
2.54
Share Volume:
22.15K
NeuroBo Pharmaceuticals 52-Week Range
52-Week High:
6.75
52-Week Low:
2.08
Sell
19
NeuroBo Pharmaceuticals (NRBO)
is a Sell
NeuroBo Pharmaceuticals Share Price Forecast
-
What is the NeuroBo Pharmaceuticals stock price today?
The NeuroBo Pharmaceuticals stock price is 2.54 USD today. -
Will NRBO stock go up or go down?
NeuroBo Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is NeuroBo Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, NeuroBo Pharmaceuticals is overvalued.
Is NeuroBo Pharmaceuticals Stock a Buy?
- NeuroBo Pharmaceuticals share price is 2.54 while NRBO 8-day exponential moving average is 2.65, which is a Sell signal.
- The stock price of NRBO is 2.54 while NeuroBo Pharmaceuticals 20-day EMA is 2.76, which makes it a Sell.
- NeuroBo Pharmaceuticals 50-day exponential moving average is 3.06 while NRBO share price is 2.54, making it a Sell technically.
- NRBO stock price is 2.54 and NeuroBo Pharmaceuticals 200-day simple moving average is 5.00, creating a Sell signal.
Technical Analysis of NeuroBo Pharmaceuticals
Should I short NeuroBo Pharmaceuticals stock?
- NRBO Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting NeuroBo Pharmaceuticals is a Sell
- NeuroBo Pharmaceuticals Relative Strength Index (RSI) is 38, which suggest NeuroBo Pharmaceuticals is oversold
- The Bollinger Bands (25) for NeuroBo Pharmaceuticals is (2.56 - 2.88), which suggest NeuroBo Pharmaceuticals is a Sell
- The Bollinger Bands (100) for NeuroBo Pharmaceuticals is (2.95 - 4.31), which suggest NeuroBo Pharmaceuticals is a Sell
* NeuroBo Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.